A Randomized, Double-Blind, Phase 3 Study of MK-7684A Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy as First Line Treatment for Participants With Metastatic Non-Small Cell Lung Cancer

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Treatment

Locations

Memorial Hospital Central
Memorial Hospital North

Study ID

Protocol Number: 22-0006

More information available at ClinicalTrials.gov: NCT05226598

Categories

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers